CA2315092A1 - Method for tissue perfusion - Google Patents

Method for tissue perfusion Download PDF

Info

Publication number
CA2315092A1
CA2315092A1 CA002315092A CA2315092A CA2315092A1 CA 2315092 A1 CA2315092 A1 CA 2315092A1 CA 002315092 A CA002315092 A CA 002315092A CA 2315092 A CA2315092 A CA 2315092A CA 2315092 A1 CA2315092 A1 CA 2315092A1
Authority
CA
Canada
Prior art keywords
tissue
solution
active agent
volume
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002315092A
Other languages
English (en)
French (fr)
Inventor
Dennis Pietronigro
Vincent Decrescito
Richard Kronenthal
Dean Mcbeth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Direct Therapeutics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2315092A1 publication Critical patent/CA2315092A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002315092A 1997-12-31 1998-12-31 Method for tissue perfusion Abandoned CA2315092A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7017597P 1997-12-31 1997-12-31
US60/070,175 1997-12-31
PCT/US1998/027926 WO1999033492A1 (en) 1997-12-31 1998-12-31 Method for tissue perfusion

Publications (1)

Publication Number Publication Date
CA2315092A1 true CA2315092A1 (en) 1999-07-08

Family

ID=22093614

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002315092A Abandoned CA2315092A1 (en) 1997-12-31 1998-12-31 Method for tissue perfusion

Country Status (5)

Country Link
EP (1) EP1042004A4 (de)
JP (1) JP2001527051A (de)
AU (1) AU746153B2 (de)
CA (1) CA2315092A1 (de)
WO (1) WO1999033492A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10111486A1 (de) * 2001-03-09 2002-10-02 Ralph R Dawirs Verwendung einer oder mehrerer neuroaktiver Substanzen zur Behandlung der Parkinsonschen Krankheit
WO2009002273A1 (en) 2007-06-26 2008-12-31 Agency For Science, Technology And Research Imaging chamber with window and micro-needle platform magnetically biased toward each other

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851527A (en) * 1988-04-18 1998-12-22 Immunomedics, Inc. Method for antibody targeting of therapeutic agents
US5051257A (en) * 1989-05-09 1991-09-24 Pietronigro Dennis D Antineoplastic solution and method for treating neoplasms
US5162115A (en) * 1989-05-09 1992-11-10 Pietronigro Dennis D Antineoplastic solution and method for treating neoplasms

Also Published As

Publication number Publication date
WO1999033492A9 (en) 1999-09-30
EP1042004A1 (de) 2000-10-11
AU2024599A (en) 1999-07-19
AU746153B2 (en) 2002-04-18
JP2001527051A (ja) 2001-12-25
EP1042004A4 (de) 2004-08-25
WO1999033492A1 (en) 1999-07-08

Similar Documents

Publication Publication Date Title
Lonser et al. Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion
US6652884B2 (en) Method for the treatment of solid tumors by albumin microparticles incorporating paclitaxel
US9149537B2 (en) Compositions and methods for the treatment of traumatic brain injury
DE69821011T2 (de) Verfahren zur Modulierung der Neovaskularisierung und/oder des Wachstums kollateraler Arterien und/oder anderer Arterien aus bestehenden arteriolären Verbindungen
WO2006024489A2 (en) Methods and compositions for the treatment of cell proliferation
KR20100122510A (ko) 중합체 파클리탁셀 접합체 및 암 치료 방법
WO2009067584A1 (en) Methods and compositions for modulating drug-polymer architecture, pharmacokinetics and biodistribution
Kofke et al. Alfentanil-induced hypermetabolism, seizure, and histopathology in rat brain
Murad et al. Image-guided convection-enhanced delivery of gemcitabine to the brainstem
CN105106186A (zh) 治疗冠状动脉和动脉的动脉瘤性蛛网膜下腔出血的方法和组合物
JP2004521112A (ja) 関節痛治療薬を製造することへの神経毒性物質の使用
Levy et al. Transrectal ultrasound-guided intraprostatic injection of absolute ethanol with and without carmustine: a feasibility study in the canine model
JP2007501239A (ja) 放射線治療と組み合わせたｖｅｇｆアンタゴニストの使用
US20070254037A1 (en) Methods and Compositions for the Treatment of Cell Proliferation
Singh et al. Volume of distribution and clearance of peptide-based nanofiber after convection-enhanced delivery
US6753005B1 (en) Method for tissue perfusion
AU746153B2 (en) Method for tissue perfusion
Lin Tetanization-induced pelvic-to-pudendal reflex plasticity in anesthetized rats
US20100035952A1 (en) Radiosensitizer Formulations and Methods for Use
US20230116621A1 (en) Drug delivery carrier including plga and beta-cyclodextrin containing drug
US20220211923A1 (en) Cryoprotective Compositions, Surgical Kits, and Methods for Protection of a Surgical Site During Cryosurgery
George et al. The production of tremor by cholinergic drugs: central sites of action
Schuster et al. Intraarterial therapy of human glioma xenografts in athymic rats using 4-hydroperoxycyclophosphamide
US20230060103A1 (en) Drug delivery systems and targeted release of pharmaceutical agents with focused ultrasound
US11752160B2 (en) Method for reducing fat by administering benzenesulfonamide compositions

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued